切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Myosin light chain kinases (MLCKs) - HBV Proteases - P-glycoprotein (P-gp) - Mixed lineage kinase domain-like protein (MLKL)

11件产品中的 1-10

页面
每页
清除全部
  1. Necrosulfonamide
    B7731 Necrosulfonamide
     1 Citation
    Target: Mixed lineage kinase domain-like protein (MLKL)
    Summary: 坏死抑制剂
      ≥46.1 mg/mL
      insoluble in H2O
  2. H-7 dihydrochloride
    B6342 H-7 dihydrochloride
    Target: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)
    Summary: 蛋白激酶抑制剂
      Soluble in DMSO
  3. Fasudil
    B3523 Fasudil
    中文名: 法舒地尔
    Target: ROCK|PKC|PKG|PKA|Myosin light chain kinases (MLCKs)
    Summary: 钙拮抗剂
      Soluble in DMSO
  4. LY335979 (Zosuquidar 3HCL)
    A8549 LY335979 (Zosuquidar 3HCL)
     1 Citation
    中文名: 唑喹达三盐酸盐
    Target: P-glycoprotein (P-gp)
    Summary: Pgb(P糖蛋白)抑制剂
      ≥17.1 mg/mL
      ≥31.9 mg/mL
  5. Lamivudine
    A8458 Lamivudine
    中文名: 拉米夫定,拉美呋定,拉米呋啶
    Target: HBV Proteases
    Summary: 核苷类似物逆转录酶抑制剂
      ≥10.5 mg/mL
      ≥89.4 mg/mL
  6. Zosuquidar
    A3956 Zosuquidar
    Target: P-glycoprotein (P-gp)|Cytochrome P450 (CYP450)
    Summary: MDR调节剂
      Soluble in DMSO
  7. Tariquidar methanesulfonate, hydrate
    A3859 Tariquidar methanesulfonate, hydrate
    中文名: 他立喹达二甲磺酸盐六水合物
    Target: P-glycoprotein (P-gp)
    Summary: P-糖蛋白抑制剂
      ≥56.2 mg/mL
      insoluble in H2O
  8. ML-7 hydrochloride
    A3626 ML-7 hydrochloride
    Target: Myosin light chain kinases (MLCKs)
    Summary: 肌球蛋白轻链激酶抑制剂
      ≥15.95 mg/mL
      ≥8.82 mg/mL
  9. Elacridar
    A3384 Elacridar
    中文名: 依克立达
    Target: P-glycoprotein (P-gp)
    Summary: BCRP抑制剂
      ≥56.4 mg/mL
      insoluble in H2O
  10. Tariquidar
    A8208 Tariquidar
     2 Citation
    中文名: 他立喹达
    Target: P-glycoprotein (P-gp)
    Summary: P-糖蛋白抑制剂
      ≥16.17 mg/mL
      insoluble in H2O

11件产品中的 1-10

页面
每页